The extraction conditions for a flavonoid-rich extract derived from the leaves of Glochidion littorale, evaluated for its anti-inflammatory potential and cytotoxicity against selected cancer cell lines, were optimized using response surface methodology (RSM) with the Box-Behnken design. The optimal conditions included an ethanol concentration of 68%, an ultrasonic extraction duration of 25 minutes, and a temperature of 60 °C. The total flavonoid content (TFC) obtained from the prepared extract was 198.18 ± 1.13 mg quercetin equivalents (QE)/g of extract, which closely aligned with the model-predicted value of 197.38 mg QE/g. Anti-inflammatory activity was assessed based on nitric oxide (NO) scavenging capacity—NO being a signaling molecule associated with inflammation. Results showed a dose-dependent reduction in NO levels, with the lowest NO concentration (31.39 ± 0.95 µM, corresponding to approximately 61% inhibition) observed at a sample concentration of 200 µg/mL. Regarding cytotoxic activity, half-maximal inhibitory concentration (IC₅₀) values were determined to be 133.48 ± 4.61 µg/mL for SK-LU-1 (lung cancer cells), 102.14 ± 0.35 µg/mL for HepG2 (liver cancer cells), and 144.20 ± 5.41 µg/mL for MKN7 (gastric cancer cells). The study concludes that the optimized flavonoid-rich extract of Glochidion littorale exhibited potent anti-inflammatory and cytotoxic potentials against lung, liver, and gastric cancer cell lines in vitro.
No takes yet. Share an insight, caveat, or question.
Thủy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: